Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells.
about
A family of AP-2 proteins down-regulate manganese superoxide dismutase expressionHydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1Identification of nucleophosmin as an NF-kappaB co-activator for the induction of the human SOD2 geneA new view of carcinogenesis and an alternative approach to cancer therapyHypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer.Expression of Mn-Superoxide Dismutase Gene in Nontumorigenic and Tumorigenic Human Mammary Epithelial CellsOxygen in human health from life to death--An approach to teaching redox biology and signaling to graduate and medical studentsOxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticlesNuclear factor kappaB-dependent mechanisms coordinate the synergistic effect of PMA and cytokines on the induction of superoxide dismutase 2Transcriptional activation of the human manganese superoxide dismutase gene mediated by tetradecanoylphorbol acetateEndogenous antioxidant enzymes and glutathione S-transferase in protection of mesothelioma cells against hydrogen peroxide and epirubicin toxicityNADPH oxidase activation is required in reactive oxygen species generation and cell transformation induced by hexavalent chromiumIdentification of New Candidate Genes and Chemicals Related to Esophageal Cancer Using a Hybrid Interaction Network of Chemicals and ProteinsAn unexpected functional link between lysosomal thiol reductase and mitochondrial manganese superoxide dismutaseNeurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient miceSuperoxide dismutase in redox biology: the roles of superoxide and hydrogen peroxideMutations in the promoter reveal a cause for the reduced expression of the human manganese superoxide dismutase gene in cancer cells.Protein expression profiling identifies maspin and stathmin as potential biomarkers of adenoid cystic carcinoma of the salivary glands.Carbonic anhydrase IX in oligodendroglial brain tumors.Transcriptomic dissection of tongue squamous cell carcinomaDeregulation of manganese superoxide dismutase (SOD2) expression and lymph node metastasis in tongue squamous cell carcinoma.Manganese superoxide dismutase induces p53-dependent senescence in colorectal cancer cells.Proteomic based identification of manganese superoxide dismutase 2 (SOD2) as a metastasis marker for oral squamous cell carcinoma.The peroxidase activity of mitochondrial superoxide dismutaseInvestigation of the highly active manganese superoxide dismutase from Saccharomyces cerevisiae.Manganese superoxide dismutase: beyond life and deathSOD mimetics are coming of age.p53-independent inhibition of proliferation and p21(WAF1/Cip1)-modulated induction of cell death by the antioxidants N-acetylcysteine and vitamin E.Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients.The structural biochemistry of the superoxide dismutases.Superoxide dismutase: an emerging target for cancer therapeutics.Superoxide dismutases in the lung and human lung diseases.The role of manganese superoxide dismutase in inflammation defenseDual function of protein kinase C (PKC) in 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced manganese superoxide dismutase (MnSOD) expression: activation of CREB and FOXO3a by PKC-alpha phosphorylation and by PKC-mediated inactivation of Akt, respSenescence of immortal human fibroblasts by the introduction of normal human chromosome 6Preferential selection of MnSOD transcripts in proliferating normal and cancer cellsOn the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies.A Nonenzymatic Hairpin DNA Cascade Reaction Provides High Signal Gain of mRNA Imaging inside Live Cells.Antioxidants in cancer care: when and how to use them as an adjunct to standard and experimental therapies.Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity.
P2860
Q24291015-8D1E9CCD-07A4-430B-A3C3-389D5C96A3E5Q24291189-5605D993-DFD6-4806-B213-011C2D15464EQ24337067-141C532E-7070-426C-825B-DE50A3E0971DQ24650249-ACF4358A-4B11-47B7-931B-99D3838616D0Q24801745-B1D6C77A-EF4E-4601-944A-5AE216A9D559Q24805807-390FD0D8-FA91-472F-99B6-91D61F5B5592Q26998478-D54EA7A1-0E15-4FE6-858C-040D1557BE00Q28075551-8B4987BA-BACA-4938-B99B-695547B997F2Q28345094-35231361-81FF-426E-9A72-545E7F365301Q28377700-5862B021-06CB-40EA-A2D1-945A34365FF6Q28379483-78350D30-1D25-47D9-861C-E5CA22AA3321Q28392194-D872279C-A5F2-419A-B7BF-1654E2FE40D9Q28548040-D7A41FD6-9961-49AF-A6A7-006923ED5699Q28589400-E9267BD9-FE3B-4F56-8559-6997541FB869Q28592978-A4C4A2E9-170F-4E57-99C7-39448AD5F4B8Q28647012-5E204CD5-E34D-4B38-B924-F4D1BD88FBDFQ31917763-A59403C2-489E-4ED9-A76C-BE9696786EF3Q33221534-B9EF540F-B09C-49DE-8E93-08BA6C7ADBE2Q33313215-E3DD1906-1B5A-4AC9-8167-F5629F5F9579Q33318572-F55A1BB7-7B18-4413-BDA4-9B3E93F9060EQ33629430-231E91EC-4274-4941-9FAA-CF3B285817EBQ33925097-F1F18742-CC21-4B7E-A022-291290821AD7Q33932201-30E45D11-D70F-4FFB-903C-843F0C957084Q34135651-8779630B-DE4C-45B8-B33A-957620BB9647Q34234929-701761F6-DE9D-4F16-A4B7-0691FFFB5FDDQ34284548-7651E09A-5EA3-47C1-BF9E-B12D7F62734BQ34743335-4773EA61-EF72-4DEC-A46D-6C48C80ACA7FQ34786224-28BBDBED-B06F-4E51-9A21-3016F5E2EAEFQ34842139-C2E2EEA4-E4B9-4ABE-8575-D887D322AADDQ34993111-F62EA229-1F6C-4786-9D1F-15CF362D7834Q35050415-30C7E4F5-6D91-4C68-A126-EB5D6E8B2B30Q35149483-1C4E559B-38B1-4D92-9164-688D7A311E9FQ35257552-42D38F00-DE51-4B99-B961-246A5B401A59Q35313664-98656B74-6BBB-482F-BCBB-2DA6DA122E0BQ35472884-0055CC5F-3ECA-484A-B6BF-3A791FF152A7Q35523765-0DA27D41-AE39-41BE-BF40-0D98CCF25E30Q35548964-F28C4BAA-10E0-4713-BDC1-295B76B5CDAEQ35596347-8DC5AB14-8217-47E6-B196-BA3D2802640AQ35611906-5131511F-4B7A-4663-8123-25B6F82D0F45Q35937789-5CFEFD74-8BFD-4062-92A7-D4D3C350A41E
P2860
Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Increased manganese superoxide ...... otype of human melanoma cells.
@ast
Increased manganese superoxide ...... otype of human melanoma cells.
@en
type
label
Increased manganese superoxide ...... otype of human melanoma cells.
@ast
Increased manganese superoxide ...... otype of human melanoma cells.
@en
prefLabel
Increased manganese superoxide ...... otype of human melanoma cells.
@ast
Increased manganese superoxide ...... otype of human melanoma cells.
@en
P2093
P2860
P356
P1476
Increased manganese superoxide ...... otype of human melanoma cells.
@en
P2093
L A Ridnour
L W Oberley
P E Swanson
P S Meltzer
S L Church
P2860
P304
P356
10.1073/PNAS.90.7.3113
P407
P577
1993-04-01T00:00:00Z